Back to Results
First PageMeta Content
Pharmacoeconomics / Quality-adjusted life year / Cost-effectiveness analysis / Outcomes research / Pharmaceutical industry / Health care / Health equity / Chronic / Cost–utility analysis / Health / Health economics / Medicine


Document Date: 2009-10-22 04:32:46

Open Document

File Size: 1,15 MB

Share Result on Facebook

City

Copenhagen / Amsterdam / Brussels / /

Company

MTA / Van Dijk LC / United BioSource Corporation / Hesselink AE / Grol RT. / iMTA / /

Continent

Africa / Asia / Europe / /

Country

Netherlands / United Kingdom / /

Currency

EUR / /

/

EntertainmentAwardEvent

Oscar / /

Event

Natural Disaster / Employment Change / Person Travel / /

Facility

Free University / Erasmus University / Franciscus Hospital / /

IndustryTerm

treatment for depression / pharmaceutical industry / disease-specific utilities / health technology assessment / medical technology assessment / pharmaceutical / healthcare decision making / Treatment of a life threatening illness / gross national product / pharmaceuticals / care for cancer / pharmaceutical expenses / insurance package / /

MedicalCondition

rare diseases / BPH / COPD / onychomycosis / illness / breast cancer / common diseases / malignant tumors / cancer / disease / thalassemia major Marieke Krol / involved illness / chronic obstructive pulmonary disease / very severe COPD / diffuse large Bcell lymphoma / Acute abdominal aortic aneurysms / same disease / such an illness / diseases / Dutch hospitals cancer / beta thalassemia major / chronic myeloid leukemia / depression / injuries / /

MedicalTreatment

open surgery / mass vaccination / /

NaturalFeature

Groot MT / /

Organization

Dutch government / World Health Organization / Dunning Committee / Dutch Breast Cancer Association / Free University Amsterdam / Dutch Health Care Insurance Board / Erasmus University Rotterdam / Dutch Council for Public Health and Health Care / Vrije Universiteit Amsterdam / Franciscus Hospital / Congress / European Commission / International Society for Pharmacoeconomics and Outcomes Research / /

Person

Elly Stolk / Carin Uyl-de / Anke Hövels / Maiwenn Al / Hove / Jan van Busschbach / Frans Rutten / Marion Lindemann / Tom van der Grinten / Onno van Rijen / Carin Uyl / Carin Uyl-de Groot / Marieke Krol / Louis Niessen / Van Gorp / Mark Oppe / Jan Oostenbrink / Ken Redekop / Maureen Rutten-van Mölken / Martine Hoogendoorn-Lips / Rudiger Sandtman / Carin Uylde Groot / Werner Brouwer / Werner Brouwer Hakkaart / Pedram Sendi / Leona Hakkaart-van Roijen / Van Doorslaer / Mark Nuijten / Leida Lamers / Lucas Goossens / Van Exel / Marc Koopmanschap / Al M / Jan Oostenbrink Maiwenn Al / Ineke de Klerk / /

Position

project leader / organizational consultant / minister / future minister / politician / minister of Health / researcher / secretary / Professor / vice director / Director / Executive / Major / professor of Health Policy / Council member / /

Product

Herceptin / /

ProvinceOrState

Zeeland / /

PublishedMedium

Health Economics / /

Technology

t-1 / EM algorithm / MVH protocol / simulation / /

URL

www.imta.nl / http /

SocialTag